Question 1

What is PharmAla Biotech?

Accepted Answer

PharmAla Biotech is a Entity.

Question 2

How often does PharmAla Biotech appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was PharmAla Biotech first tracked by Ergen?

Accepted Answer

First tracked on Aug 05, 2026.

Question 4

When was PharmAla Biotech last mentioned in news?

Accepted Answer

Last active on Aug 05, 2026.

Question 5

What is PharmAla Biotech's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is PharmAla Biotech in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving PharmAla Biotech?

Accepted Answer

Jupiter Neurosciences 1-for-75 Reverse Stock Split (Aug 05, 2026, 6 articles).

Question 8

How did the "Jupiter Neurosciences 1-for-75 Reverse Stock Split" event impact PharmAla Biotech?

Accepted Answer

PharmAla Biotech is the licensor of ALA-002, a psychedelic compound in Jupiter's pipeline. The reverse split does not directly affect PharmAla, but it is part of Jupiter's broader strategy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.